Modulation of Adriamycin Resistance in Human Breast Carcinoma MCF‐7 Cells in vitro and in vivo by Medroxyprogesterone Acetate

The combination effect of adriamycin (ADM) and medroxyprogesterone acetate (MPA) was examined in vitro against human breast carcinoma MCF‐7 and its ADM‐resistant line (MCF‐7/ADM). MCF‐7 cells, which are positive for estrogen receptors, progesterone receptors and high‐affinity MPA‐binding activity, w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Jpn J Cancer Res
Principais autores: Ishida, Hiroyuki, Okabe, Masami, Gomi, Katsushige, Horiuchi, Ryuya, Mikami, Koji, Naito, Mikihiko, Tsuruo, Takashi
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 1994
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5919497/
https://ncbi.nlm.nih.gov/pubmed/8014112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1994.tb02393.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados